CTAS
53
-3
PVH
60
-4
COP
57
-2
GT
56
-3
WEC
53
5
DE
42
3
ALL
50
2
MRK
17
-5
IRM
41
3
SO
57
6
KMX
61
-3
ABT
59
2
CVS
41
-4
SIG
44
-3
MU
28
-3
SLB
52
-3
TDC
67
-4
SE
60
-3
HRB
59
2
PG
50
2
CTAS
53
-3
PVH
60
-4
COP
57
-2
GT
56
-3
WEC
53
5
DE
42
3
ALL
50
2
MRK
17
-5
IRM
41
3
SO
57
6
KMX
61
-3
ABT
59
2
CVS
41
-4
SIG
44
-3
MU
28
-3
SLB
52
-3
TDC
67
-4
SE
60
-3
HRB
59
2
PG
50
2
Financhill
Back

Themes Gold Miners ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
84

AUMI
Themes Gold Miners ETF

Last Price:
35.15
Seasonality Move:
--
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
84
Themes Gold Miners ETF (AUMI) is a Buy

Is Themes Gold Miners ETF a Buy, Sell or Hold?

  • The current Themes Gold Miners ETF [AUMI] share price is $35.02. The Score for AUMI is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
  • AUMI is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AUMI Stock Price Chart

What is Themes Gold Miners ETF's stock price today?

  • The Themes Gold Miners ETF share price today is $35.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUMI is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

AUMI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.88 Sell
Relative Strength Index (14 RSI): 35.15 Sell
Chaikin Money Flow: -1559 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.77 - 40.95) Sell
Bollinger Bands (100): (33.26 - 38.66) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

AUMI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.31 Sell
20-day SMA: 38.69 Sell
50-day SMA: 38.05 Sell
200-day SMA: 32.59 Buy
8-day EMA: 36.23 Sell
20-day EMA: 37.58 Sell
50-day EMA: 37.51 Sell
200-day EMA: 32.84 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Themes Gold Miners ETF Earnings Growth & AUMI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Themes Gold Miners ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):